ONC Q4 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.5B+32.8% YoY

Gross Profit

$1.4B90.5% margin

Operating Income

$185M12.4% margin

Net Income

$67M4.4% margin

EPS (Diluted)

$7.15

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

$417M

Free Cash Flow

$131M

Stock-Based Comp.

$757M

Balance Sheet

Total Assets

$8.2B

Total Liabilities

$3.8B

Stockholders' Equity

$4.4B

Cash & Equivalents

$4.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.1B	+32.8%
Gross Profit	$1.4B	$967M	+40.2%
Operating Income	$185M	-$79M	+333.0%
Net Income	$67M	-$152M	+143.8%

Revenue Segments

Product

$1.9B98%

Collaboration

$39M2%

Geographic Segments

UNITED STATES

$864M60%

CHINA

$407M28%

Europe

$174M12%